ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Genotypic and phylogenetic characterization of Salmonella Minnesota ST548 strains with potential risk to public health.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salmonella Minnesota ST548 has emerged as an important serovar in the poultry industry and has been detected in food products. Five nonclonal S. Minnesota isolates from poultry in southeastern Brazil were characterized using whole-genome sequencing (WGS), and 263 database sequences were analyzed for virulence genes, antimicrobial resistance genes, and phylogenetic relationships. Among the analyzed sequences, 191 multidrug-resistant (MDR) strains carried antimicrobial resistance genes (ARGs) conferring resistance to aminoglycosides (aac(6')-Iaa, aph(3')-Ia and aadA1), quinolones (qnrB19), tetracycline (tetA), sulfonamides (sul2), and beta-lactams (bla
Indexed as
Identifiers
42909713What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.